News from NORD

Collaborative Effort Is Underway to Screen Small Molecules for Therapeutic Potential for NGLY1 Deficiency

Publish date: December 7, 2017

 

A collaboration involving a patient organization (NGLY1.org), government (NIH National Center for Advancing Translational Sciences) and industry (Retrophin) is underway to screen hundreds of thousands of small molecules for their therapeutic potential in NGLY1 deficiency.

Recommended Reading

Nominate a Colleague or Patient for a NORD Rare Impact Award
MDedge Family Medicine
NORD Reopens Call for Abstracts for Research Grants
MDedge Family Medicine
Poster Abstracts Due January 31 for European Conference on Rare Diseases and Orphan Products
MDedge Family Medicine
Beta Version of ClinicalTrials.gov Website Available for Public Testing
MDedge Family Medicine
NORD Welcomes Five New Member Organizations
MDedge Family Medicine
Guthy-Jackson Charitable Foundation Produces New NMO Podcast
MDedge Family Medicine
New Book Chronicles Advances in Understanding NMO and Provides Blueprint for Other Rare Diseases
MDedge Family Medicine
Register Now for Adrenal Insufficiency United Conference
MDedge Family Medicine
Homocystinuria Research Grants Are Available
MDedge Family Medicine
15th International Symposium on MPS and Related Diseases Is Planned
MDedge Family Medicine